Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Methotrexate +/- Cytarabine in PCNSL
NCT00210314Phase 2Completed
- Sponsor
- International Extranodal Lymphoma Study Group
- Start
- Jul 2003
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cytarabine in primary central nervous system lymphoma (PCNSL), sponsored by International Extranodal Lymphoma Study Group. Started Jul 2003; status: completed.
02
Drugs
cytarabine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00210314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210314.